Evidence map›Paper›PMID 37523757›Full record

ArticleThe Journal of infectious diseases2024

Revaccination for Hepatitis B in Previous Nonresponders Following Hepatitis C Eradication.

Jesse G Powell, Spencer R Goble, Jose D Debes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jesse G PowellDepartment of Gastroenterology and Hepatology, Hennepin Healthcare, Minneapolis, Minnesota, USA.ORCID 0000-0002-6827-680X
Spencer R GobleDepartment of Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA.ORCID 0000-0003-2076-2670
Jose D DebesDepartment of Gastroenterology and Hepatology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Hennepin Healthcare Research Institute · USUniversity of Minnesota · US

Funding

Impact of Hepatitis C and HIV coinfection on biological aging and hepatocellular carcinoma riskR21TW012390 · FIC · UNIVERSITY OF MINNESOTA · PI DEBES, JOSE DANIEL · 2022 to 2023
$500k
FIC NIH HHS R21 TW012390University of Minnesota 1R21TW012390-01A1
6 · The paper itself

Abstract

backgroundPatients with chronic hepatitis C virus (HCV) do not respond to hepatitis B virus (HBV) vaccination as efficiently as the general population. We assessed if revaccination after HCV treatment resulted in improved response.

methodsPrevious HBV vaccine nonresponders were prospectively recruited for revaccination after HCV eradication. Hepatitis B surface antibody (HBsAb) testing was performed 1 month after series completion.

resultsFollow-up HBsAb testing was performed in 31 of 34 enrolled patients with 21 (67.7%) reactive results. There were no significant differences in HBsAb reactivity based on age, sex, race, or advanced fibrosis presence.

conclusionsHBV vaccine nonresponders should be considered for revaccination following HCV cure.

Indexed as

Hepatitis BHepatitis CHepatitis C, ChronicHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansImmunization, SecondaryHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B Vaccinesdirect-acting antiviralhepatitis B virus vaccinehepatitis B virus vaccine nonresponsehepatitis C virus

Identifiers

PMID37523757
PMCPMC13641195
OpenAlexW4385408903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.